Abante, Joel P.
HRN: 06-56 - 95 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2022
CEFUROXIME 1.5GM (VIAL)
04/23/2022
04/30/2022
IV
1.5g
Q8H
Pneumonia
Waiting Final Action